Biotechnology Stocks II Performance Guide: Revance Therapeutics, Inc. (RVNC)
RVNC has no dividends.
Table and Chart of RVNC Performance
See what a $1,000 investment in RVNC is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| RVNC Returns | |
|---|---|
| Start Date | May-30-2014 |
| Start Price | $31.49 |
| End Date | May-16-2024 |
| End Price | $3.16 |
| # Prices | 121 |
| Min Date | May-16-2024 |
| Min Price | $3.16 |
| Max Date | Oct-30-2015 |
| Max Price | $39.17 |
| Total Return | -89.97% |
| Annualized Return | -20.39% |
| Current Value of $1,000 Purchase | $100 |
| Number Returns | 7,260 |
| Average Return | -2.88% |
| Number Profitable Returns | 3,087 |
| Percent Profitable Returns | 42.52% |
| Number Unprofitable Returns | 4,173 |
| Percent Unprofitable Returns | 57.48% |
| Profitable to Unprofitable Returns Ratio | 0.74 |
| RVNC Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $345,726,000 |
| Beta | 1.155 | Price to Sales | 1.84 |
| Earnings per Share | $-3.7700 |
| PE Ratio | None |
| PE to Growth Ratio | -0.64 |
| Price to Book | 12.3 |
| PRICE DATA | |
| 52 Week High | $33.09 |
| 52 Week Low | $3 |
| Analyst Target Price | $12.91 |
| 50-Day Moving Average | $4.454 |
| 200-Day Moving Average | $8.77 |
| FINANCIAL DATA | |
| Revenue per Share | $2.752 |
| Revenue | $240,202,000 |
| Profit Margin | -132.1% |
| Return on Equity | -2097% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
RVNC Compare Returns with S&P 500
RVNC Trendline Chart
RVNC Moving Average Chart
RVNC Stock Return Map - See Patterns of Gains and Losses
RVNC Stock Returns/Purchase Dates